
UPC ruling restricts Siemens mammography system sales
The Unified Patent Court found that Siemens Healthineers’ Mammomat B.brilliant infringed Hologic’s European patent covering focal-spot technology for mammography and tomosynthesis.
Company
German medical technology company headquartered in Erlangen, Germany, providing imaging, diagnostics, and precision therapy solutions. A subsidiary of Siemens AG, the company spans CT, MRI, ultrasound, X-ray, molecular imaging, and laboratory diagnostics.

The Unified Patent Court found that Siemens Healthineers’ Mammomat B.brilliant infringed Hologic’s European patent covering focal-spot technology for mammography and tomosynthesis.

The $6.9M SHIELD project will use AI and simulation tools to help hospitals prioritize security upgrades for connected medical equipment.

The $8M Siemens Healthineers system will support research into cancer, stroke, neurological disorders, chronic pain, musculoskeletal injury, and mental health conditions.

The 25-patient oncology comparison found an 83% acquisition-time reduction and higher reader scores for image quality on a 128-cm long-axial field-of-view PET/CT system.

Siemens Healthineers and Cercare Medical are pairing Syngo DynaCT Multiphase with Neurosuite to support perfusion imaging during acute stroke interventions.

The system combines Syngo.CT Coronary Cockpit and Syngo PCI Connect to transfer preprocessed coronary CT angiography data into the cath lab.

Siemens Healthineers has received FDA clearance for 6 systems in its Artis interventional imaging portfolio. All 6 systems feature the Optiq AI imaging chain, which analyzes and optimizes image data in real time.

Siemens Healthineers lowered its 2026 outlook after pressure in its diagnostics business, particularly in China. The company also announced leadership changes across diagnostic imaging, advanced therapies, EMEA, and human resources.

ARPA-H awarded Siemens Healthineers’ Varian business up to $60M over 5 years to advance photon Flash radiotherapy.

Siemens plans to put the direct spin-off of Siemens Healthineers shares to a shareholder vote at its February 2027 Annual General Meeting.